<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36039714</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1972-6481</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Giornale italiano di cardiologia (2006)</Title><ISOAbbreviation>G Ital Cardiol (Rome)</ISOAbbreviation></Journal><ArticleTitle>[Long COVID: nosographic aspects and clinical epidemiology].</ArticleTitle><Pagination><StartPage>651</StartPage><EndPage>662</EndPage><MedlinePgn>651-662</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1714/3860.38447</ELocationID><Abstract><AbstractText>Recent evidence shows that a range of persistent or new symptoms can manifest after 4-12 weeks in a subset of patients who have recovered from acute SARS-CoV-2 infection, and this condition has been coined long COVID by COVID-19 survivors among social support groups. Long COVID can affect the whole spectrum of people with COVID-19, from those with very mild acute disease to the most severe forms. Like the acute form, long COVID has multisystemic aspects. Patients can manifest with a very heterogeneous multitude of symptoms, including fatigue, post-exertional malaise, dyspnea, cognitive impairment, sleep disturbances, anxiety and depression, muscle pain, brain fog, anosmia/dysgeusia, headache, and limitation of functional capacity, which impact their quality of life. Because of the extreme clinical heterogeneity, and also due to the lack of a shared, specific definition, it is very difficult to know the real prevalence and incidence of this condition. Risk factors for developing long COVID would be female sex, initial severity, and comorbidities. Globally, with the re-emergence of new waves, the population of people infected with SARS-CoV-2 continues to expand rapidly, necessitating a more thorough understanding of potential sequelae of COVID-19. This review summarizes up to date definitions and epidemiological aspects of long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abrignani</LastName><ForeName>Maurizio G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>U.O. Cardiologia, P.O. S. Antonio Abate, Asp Trapani.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maloberti</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiologia 4, ASST Grande Ospedale Metropolitano Niguarda, Milano.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Temporelli</LastName><ForeName>Pier Luigi</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Divisione Cardiologia Riabilitativa, ICS Maugeri, IRCCS Gattico-Veruno (NO).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binaghi</LastName><ForeName>Giulio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>S.C. Cardiologia, ARNAS G. Brotzu, Cagliari.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cesaro</LastName><ForeName>Arturo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universit&#xe0; della Campania "L. Vanvitelli", Napoli - Divisione Cardiologia, AORN Sant'Anna e San Sebastiano, Caserta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciccirillo</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>U.O.C. Cardiologia, P.O. V. Fazzi, Lecce.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliva</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cardiologia 2-Insufficienza Cardiaca e Trapianti, Dipartimento Cardiotoracovascolare "A. De Gasperis", ASST Grande Ospedale Metropolitano Niguarda, Milano.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabrielli</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>U.O.C. Cardiologia-UTIC, Azienda Ospedaliera San Camillo Forlanini, Roma.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riccio</LastName><ForeName>Carmine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>U.O.S.D. Follow-Up del Paziente Post-Acuto, Dipartimento Cardio-Vascolare, AORN Sant'Anna e San Sebastiano, Caserta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gulizia</LastName><ForeName>Michele Massimo</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>U.O.C. Cardiologia, Ospedale Garibaldi-Nesima, ARNAS "Garibaldi", Catania - Fondazione per il Tuo cuore-Heart Care Foundation, Firenze.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colivicchi</LastName><ForeName>Furio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>U.O.C. Cardiologia Clinica e Riabilitativa, P.O. San Filippo Neri, ASL Roma 1, Roma.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ita</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Long COVID: aspetti nosografici ed epidemiologia clinica.</VernacularTitle></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>G Ital Cardiol (Rome)</MedlineTA><NlmUniqueID>101263411</NlmUniqueID><ISSNLinking>1827-6806</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>4</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36039714</ArticleId><ArticleId IdType="doi">10.1714/3860.38447</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>